EUVIMEDEUVIMED entdecken
Crossref

Harmine and extendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system

Rosselot C, Li Y, Wang P, Alvarsson A, Beliard K, Lu G, et al

Yearbook of Paediatric Endocrinology · 30.09.2025

DOI: 10.1530/ey.22.10.15 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Rosselot C und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

C, R., Y, L., P, W., A, A., K, B., G, L., & al, E. (2025). Harmine and extendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.10.15

Vancouver

C R, Y L, P W, A A, K B, G L, et al. Harmine and extendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.10.15

BibTeX
@article{C2025,
  author = {C, Rosselot and Y, Li and P, Wang and A, Alvarsson and K, Beliard and G, Lu and al, et},
  title = {Harmine and extendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system},
  journal = {Yearbook of Paediatric Endocrinology},
  year = {2025},
  doi = {10.1530/ey.22.10.15}
}
Kostenlos starten →